- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00484796
Trigeminus-evoked Somatosensory Potentials in Patients Undergoing Carotid Surgery (TRISEP)
October 26, 2012 updated by: Armin Sablotzki, MD, Klinikum St. Georg gGmbH
Comparison of Trigeminus-evoked Somatosensory Potentials (TRI-SEP) and Medianus-evoked Somatosensory Potentials (MED-SEP) in Patients Undergoing Carotid Surgery
Hypothesis: Trigeminus-evoked somatosensory potentials (TRI-SEP) may be used as an alternative technique to medianus-evoked somatosensory potentials (MED-SEP) in patients undergoing elective carotid surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
For CNS-monitoring somatosensory-evoked responses ba electrical stimulation of the contralateral median nerve are established: A reduction of amplitude and a delay in latency may represent a sensible marker of imminent cerebral ischemia.
This study will evaluate a new concept by using trigeminal nerve evoked somatosensory evoked potentials in comparison to the established MED-SEP.
Beside the comparison of two methods of neuromonitoring, this study will investigate the neurological long-term outcome (90-day evaluation) with different neuropsychological tests for the detection of cognitive deficits.
Study Type
Observational
Enrollment (Actual)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sachsen
-
Leipzig, Sachsen, Germany, 04129
- Klinikum St. Georg, Clinics of Anesthesiology, Critical Care and Pain Therapy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing carotid surgery
Description
Inclusion Criteria:
- Age >= 18 years
- Agreement with study procedure
- Elective carotid surgery
Exclusion Criteria:
- Inability to take somatosensory potentials
- Inability to respond to neuropsychological tests
- Severe preoperative neurological deficit
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1
Patients undergoing carotid surgery
|
intraoperative neurophysiological monitoring
intraoperative neurophysiologic monitoring
neurological short- and longterm outcome
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
detection of episodes of cerebral ischemia during carotid surgery
Time Frame: intraoperative, 28 days, and 60 days after surgery
|
intraoperative, 28 days, and 60 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Armin R Sablotzki, MD, Klinikum St. Georg, Clinics of Anesthesiology, Critical Care and Pain Therapy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
February 1, 2012
Study Registration Dates
First Submitted
June 8, 2007
First Submitted That Met QC Criteria
June 8, 2007
First Posted (Estimate)
June 11, 2007
Study Record Updates
Last Update Posted (Estimate)
October 29, 2012
Last Update Submitted That Met QC Criteria
October 26, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ISRCTN47041942
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carotid Surgery
-
VA Office of Research and DevelopmentCompletedSurgery | Cholecystectomy, Laparoscopic | Arthroplasty, Replacement, Hip | Prostatectomy | Endarterectomy, CarotidUnited States
-
St. Josef Hospital BochumCompletedVascular Surgery Patient With PAD / Carotid StenosisGermany
-
Brighton and Sussex University Hospitals NHS TrustCompletedStroke | Anaesthesia | Carotid Stenosis | Surgery | TIAUnited Kingdom
-
Xuanwu Hospital, BeijingUnknownStroke | Carotid Stenosis | SurgeryChina
-
Institute for Cardiovascular Diseases "Dedinje"RecruitingStroke | Carotid Artery Diseases | Ischemic Postconditioning | Carotid SurgerySerbia
-
University Hospital, Clermont-FerrandCompletedEndovascular Carotid Surgery | Preoperative HypotensionFrance
-
Linda BlockGöteborg UniversityRecruitingIschemic Stroke | Surgery | Anesthesia | Artery Occlusion | Ischemia, Cerebral | Artery Carotid StenosiSweden
-
Silk Road MedicalCompletedCarotid Artery Plaque | Carotid Stenosis | Carotid Artery Diseases | Carotid Atherosclerosis | Carotid DiseaseUnited States, Spain
-
Xuanwu Hospital, BeijingRecruitingCarotid Artery Plaque | Carotid Artery Stenting | Carotid EndarterectomyChina
-
Beijing Tiantan HospitalRecruitingCarotid EndarterectomyChina
Clinical Trials on MED-SEP
-
Sumitomo Pharma America, Inc.CompletedSchizophreniaUnited States, Serbia, Colombia, Bulgaria, Russian Federation, Ukraine
-
Sumitomo Pharma Co., Ltd.TerminatedSchizophreniaJapan, Taiwan, China, Philippines
-
Sumitomo Pharma America, Inc.CompletedSchizophreniaUnited States, Serbia, Croatia, Bulgaria, Latvia, Russian Federation, Ukraine
-
SunovionCompleted
-
USDA Beltsville Human Nutrition Research CenterPenn State UniversityCompletedHealthy VolunteersUnited States
-
SunovionCompletedDepressive Episode | Bipolar 1 DepressionJapan, Serbia, United States, Poland, Russian Federation, Bulgaria, Slovakia, Ukraine
-
Sumitomo Pharma Co., Ltd.Terminated
-
Sumitomo Pharma America, Inc.TerminatedSchizophreniaUnited States, Serbia, Ukraine, Croatia, Colombia, Russian Federation, Bulgaria, Latvia
-
Sumitomo Pharma Co., Ltd.Completed
-
SunovionCompletedSchizophreniaUnited States, Ukraine, Russian Federation, Hungary, Romania